IN2014CN03072A - - Google Patents
Info
- Publication number
- IN2014CN03072A IN2014CN03072A IN3072CHN2014A IN2014CN03072A IN 2014CN03072 A IN2014CN03072 A IN 2014CN03072A IN 3072CHN2014 A IN3072CHN2014 A IN 3072CHN2014A IN 2014CN03072 A IN2014CN03072 A IN 2014CN03072A
- Authority
- IN
- India
- Prior art keywords
- compositions
- directed
- production
- methods
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/72—Increased effector function due to an Fc-modification
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553335P | 2011-10-31 | 2011-10-31 | |
| PCT/US2012/062211 WO2013066761A1 (en) | 2011-10-31 | 2012-10-26 | Method for preparing antibodies having improved properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN03072A true IN2014CN03072A (ru) | 2015-07-31 |
Family
ID=48192651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3072CHN2014 IN2014CN03072A (ru) | 2011-10-31 | 2012-10-26 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140286946A1 (ru) |
| EP (1) | EP2773661A4 (ru) |
| JP (1) | JP2014532661A (ru) |
| KR (1) | KR20140097245A (ru) |
| CN (1) | CN104011076A (ru) |
| AU (1) | AU2012332840A1 (ru) |
| CA (1) | CA2853809A1 (ru) |
| IN (1) | IN2014CN03072A (ru) |
| WO (1) | WO2013066761A1 (ru) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| CA2916594C (en) | 2013-07-04 | 2020-03-10 | Novartis Ag | O-mannosyltransferase deficient filamentous fungal cells and methods of use thereof |
| US9782476B2 (en) | 2013-09-06 | 2017-10-10 | Academia Sinica | Human iNKT cell activation using glycolipids with altered glycosyl groups |
| EP3049442A4 (en) | 2013-09-26 | 2017-06-28 | Costim Pharmaceuticals Inc. | Methods for treating hematologic cancers |
| JOP20200094A1 (ar) | 2014-01-24 | 2017-06-16 | Dana Farber Cancer Inst Inc | جزيئات جسم مضاد لـ pd-1 واستخداماتها |
| JOP20200096A1 (ar) | 2014-01-31 | 2017-06-16 | Children’S Medical Center Corp | جزيئات جسم مضاد لـ tim-3 واستخداماتها |
| TWI654202B (zh) * | 2014-05-27 | 2019-03-21 | 中央研究院 | 增進抗體功效之通用糖型之組合物及方法 |
| CA2950440A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
| AU2015267047A1 (en) | 2014-05-27 | 2017-01-05 | Academia Sinica | Anti-CD20 glycoantibodies and uses thereof |
| AU2015267044A1 (en) | 2014-05-28 | 2016-12-15 | Academia Sinica | Anti-TNF-alpha glycoantibodies and uses thereof |
| CN108064266A (zh) | 2014-07-21 | 2018-05-22 | 格利科斯芬兰公司 | 在丝状真菌中具有哺乳动物样n-聚糖的糖蛋白的制备 |
| JO3663B1 (ar) | 2014-08-19 | 2020-08-27 | Merck Sharp & Dohme | الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين |
| CN107206071A (zh) | 2014-09-13 | 2017-09-26 | 诺华股份有限公司 | Alk抑制剂的联合疗法 |
| CN109069570A (zh) | 2015-12-16 | 2018-12-21 | 默沙东公司 | 抗lag3抗体和抗原结合片段 |
| EP3500594A4 (en) | 2016-08-22 | 2020-03-11 | Cho Pharma Inc. | ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE |
| CA3067847A1 (en) * | 2017-07-06 | 2019-01-10 | Regeneron Pharmaceuticals, Inc. | Cell culture process for making a glycoprotein |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080206246A1 (en) * | 2006-04-05 | 2008-08-28 | Ravetch Jeffrey V | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| CA2655246A1 (en) * | 2006-06-09 | 2007-12-21 | University Of Maryland, Baltimore | Glycosylation engineered antibody therapy |
| FR2912154B1 (fr) * | 2007-02-02 | 2012-11-02 | Glycode | Levures genetiquement modifiees pour la production de glycoproteines homogenes |
| AU2011258425B2 (en) * | 2010-05-27 | 2015-12-10 | Merck Sharp & Dohme Llc | Method for preparing antibodies having improved properties |
-
2012
- 2012-10-26 CA CA2853809A patent/CA2853809A1/en not_active Abandoned
- 2012-10-26 AU AU2012332840A patent/AU2012332840A1/en not_active Abandoned
- 2012-10-26 IN IN3072CHN2014 patent/IN2014CN03072A/en unknown
- 2012-10-26 EP EP12845161.4A patent/EP2773661A4/en not_active Withdrawn
- 2012-10-26 US US14/354,931 patent/US20140286946A1/en not_active Abandoned
- 2012-10-26 KR KR1020147014365A patent/KR20140097245A/ko not_active Application Discontinuation
- 2012-10-26 WO PCT/US2012/062211 patent/WO2013066761A1/en active Application Filing
- 2012-10-26 JP JP2014539067A patent/JP2014532661A/ja active Pending
- 2012-10-26 CN CN201280065393.3A patent/CN104011076A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140097245A (ko) | 2014-08-06 |
| CN104011076A (zh) | 2014-08-27 |
| CA2853809A1 (en) | 2013-05-10 |
| US20140286946A1 (en) | 2014-09-25 |
| WO2013066761A1 (en) | 2013-05-10 |
| JP2014532661A (ja) | 2014-12-08 |
| EP2773661A1 (en) | 2014-09-10 |
| AU2012332840A1 (en) | 2014-05-15 |
| EP2773661A4 (en) | 2015-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN03072A (ru) | ||
| JOP20180103B1 (ar) | التركيب الصيدلاني للكاربيتوسين | |
| PH12014501427B1 (en) | Anti-phf-tau antibodies and their uses | |
| UA110354C2 (ru) | Противовирусные соединения | |
| MX2022000026A (es) | Anticuerpos para tau. | |
| JO3773B1 (ar) | معدلات p2x7 | |
| MX2018010572A (es) | Inmunoglobulinas heterodimericas. | |
| MX2015006324A (es) | Metodos para la fabricacion de polipeptidos proteoliticamente procesados. | |
| IN2013MN00501A (ru) | ||
| IN2015DN00127A (ru) | ||
| IN2015DN03029A (ru) | ||
| MX337549B (es) | Derivados de insulina que contienen enlaces disulfuro adicionales. | |
| IN2015DN00372A (ru) | ||
| MX348325B (es) | Composicion que contiene galacto-oligosacarido y un metodo para producirla. | |
| IN2014DN09450A (ru) | ||
| IN2014DN00254A (ru) | ||
| MX350392B (es) | Aceite de sandalo y sus usos. | |
| PH12016501201A1 (en) | Synthesis of ent-progesterone and intermediates thereof | |
| MX347541B (es) | Analogos de acido sialico. | |
| IN2013MU01113A (ru) | ||
| WO2013181599A3 (en) | Methods related to rituximab | |
| MX2013014420A (es) | Composiciones en gel. | |
| IN2013MU01290A (ru) | ||
| MX337610B (es) | Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma. | |
| MX2016005511A (es) | Intermediarios y metodos para sintetizar derivados de calicheamicina. |